ABBN.SW: $86.14 ▲ 0.04 (0.05%)ASML.AS: $1,562.20 ▲ 1.40 (0.09%)ENR.DE: $159.84 ▼ -2.66 (-1.64%)GLEN.L: $535.80 ▲ 0.50 (0.09%)IFX.DE: $81.06 ▲ 0.50 (0.62%)NOKIA.HE: $12.18 ▲ 0.18 (1.50%)RIO.L: $7,283.00 ▲ 19.00 (0.26%)AMD: $519.85 ▼ -31.78 (-5.76%)INTC: $132.28 ▼ -8.66 (-6.14%)MU: $1,051.77 ▼ -159.61 (-13.18%)WDC: $670.75 ▼ -61.87 (-8.45%)AAPL: $294.30 ▼ -2.71 (-0.91%)AMZN: $234.11 ▲ 1.32 (0.57%)NVDA: $200.04 ▼ -8.61 (-4.13%)AMAT: $585.88 ▼ -54.30 (-8.48%)CIEN: $459.85 ▼ -0.48 (-0.10%)STX: $1,038.59 ▼ -55.45 (-5.07%)

Company Details

IceCure Medical Ltd

ICCM - NASDAQ

Identifiants & Marche

Ticker ICCM
ISIN IL0011224156
CIK 0001584371
Bourse NASDAQ
Devise USD

Classification

Secteur Healthcare
Industrie Medical - Devices

Entreprise

Pays IL
Siege N/A
Fondee N/A
Site Web Lien

Description

IceCure Medical Ltd, a medical device company, engages in the research, development, and commercialization of medical devices for cryoablation (freezing) of tumors in the human body. It offers ProSense system, a cryoablation solution for the treatment of breast tumors. The company was incorporated in 2006 and is headquartered in Caesarea, Israel.